Spyryx Biosciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

Spyryx Biosciences General Information

Description

Operator of a privately held, clinical-stage biopharmaceutical company intended to create innovative therapeutics to address severe lung diseases. The company's therapeutics utilizes inhaled peptides to treat severe pulmonary diseases where mucus accumulation and obstructions are key to disease progression, enabling healthcare institutes to get peptide for the treatment of orphan lung and respiratory diseases like Cystic Fibrosis and Chronic Obstructive Pulmonary Disorder.

Contact Information

Formerly Known As
Spyryx
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 801-10 Capitola Drive
  • Durham, NC 27713
  • United States
+1 (919)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 801-10 Capitola Drive
  • Durham, NC 27713
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spyryx Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Sep-2019 Completed Out of Business
3. Later Stage VC 04-Oct-2018 Completed Clinical Trials - Phase 2
2. Grant 20-Jun-2017 $5M $18.2M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 24-Apr-2015 $18.2M $18.2M Completed Product Development
To view Spyryx Biosciences’s complete valuation and funding history, request access »

Spyryx Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Spyryx Biosciences’s complete cap table history, request access »

Spyryx Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a privately held, clinical-stage biopharmaceutical company intended to create innovative therapeutics to add
Pharmaceuticals
Durham, NC
10 As of 2017

London, United Kingdom
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spyryx Biosciences Competitors (75)

One of Spyryx Biosciences’s 75 competitors is Verona Pharma, a Private Debt Financed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verona Pharma Private Debt Financed London, United Kingdom
Theravance Biopharma Corporation San Francisco, CA
Edesa Biotech Formerly VC-backed Markham, Canada
The Zambon Group Private Debt Financed Bresso, Italy
Rallybio Formerly VC-backed New Haven, CT
You’re viewing 5 of 75 competitors. Get the full list »

Spyryx Biosciences Patents

Spyryx Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3554527-A1 Saline formulations of splunc1 peptides Inactive 13-Dec-2016
CA-3046361-A1 Saline formulations of splunc1 peptides Inactive 13-Dec-2016
US-20200031866-A1 Peptide inhibitors of sodium channels Inactive 29-Sep-2016
AU-2015330895-A1 Improved peptide inhibitors of sodium channels Inactive 08-Oct-2014
US-9796768-B2 Peptide inhibitors of sodium channels Inactive 08-Oct-2014 C07K7/06
To view Spyryx Biosciences’s complete patent history, request access »

Spyryx Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spyryx Biosciences FAQs

  • When was Spyryx Biosciences founded?

    Spyryx Biosciences was founded in 2013.

  • Where is Spyryx Biosciences headquartered?

    Spyryx Biosciences is headquartered in Durham, NC.

  • What is the size of Spyryx Biosciences?

    Spyryx Biosciences has 10 total employees.

  • What industry is Spyryx Biosciences in?

    Spyryx Biosciences’s primary industry is Pharmaceuticals.

  • Is Spyryx Biosciences a private or public company?

    Spyryx Biosciences is a Private company.

  • What is Spyryx Biosciences’s current revenue?

    The current revenue for Spyryx Biosciences is .

  • How much funding has Spyryx Biosciences raised over time?

    Spyryx Biosciences has raised $29.1M.

  • Who are Spyryx Biosciences’s competitors?

    Verona Pharma, Theravance Biopharma, Edesa Biotech, The Zambon Group, and Rallybio are some of the 75 competitors of Spyryx Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »